Jeffrey Louis GOLDBERG,Cahil MCGOVERN,Weng TAO,Konrad A. KAUPER
申请号：
US16563048
公开号：
US20200197297A1
申请日:
2019.09.06
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Described herein are methods and devices for the long term treatment of ophthalmic disorders. Also disclosed are encapsulated cell therapy (ECT) devices that secrete a biologically active molecule and methods for using the same for the treatment of various kinds of ophthalmic disorders, including retinitis pigmentosa, geographic atrophy (dry age-related macular degeneration), glaucoma and/or macular telangiectasia.
